134 related articles for article (PubMed ID: 12798520)
1. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
[TBL] [Abstract][Full Text] [Related]
3. The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient.
Dell'Utri D; Passariello M
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):570-2. PubMed ID: 16884992
[No Abstract] [Full Text] [Related]
4. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report.
Marson F; Farnia A; Callegher L; Casagrande L; Surdu M; Sarpellon M
Minerva Anestesiol; 2006; 72(7-8):675-82. PubMed ID: 16865086
[TBL] [Abstract][Full Text] [Related]
5. [Activated recombinant factor VII for bleeding after a kidney transplant: reflections].
Pajares A; Larrea L
Rev Esp Anestesiol Reanim; 2006 Apr; 53(4):266-7; author reply 268. PubMed ID: 16711505
[No Abstract] [Full Text] [Related]
6. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
Aguilar C; Lucía JF
Am J Hematol; 2007 Mar; 82(3):246-7. PubMed ID: 16924645
[No Abstract] [Full Text] [Related]
7. Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass.
Naik VN; Mazer CD; Latter DA; Teitel JM; Hare GM
Can J Anaesth; 2003; 50(6):599-602. PubMed ID: 12826554
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis.
Karkouti K; Beattie WS; Wijeysundera DN; Yau TM; McCluskey SA; Ghannam M; Sutton D; van Rensburg A; Karski J
Transfusion; 2005 Jan; 45(1):26-34. PubMed ID: 15647015
[TBL] [Abstract][Full Text] [Related]
9. [Application of recombinant activated factor VII in gynecological intervention (case report)].
Nacheva A; Gateva Zh; Atanasova V
Akush Ginekol (Sofiia); 2004; 43 Suppl 4():3-5. PubMed ID: 15673003
[No Abstract] [Full Text] [Related]
10. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
El Kinge AR; Mahfouz RA; Shamseddine AI; Taher AT
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):577-9. PubMed ID: 17762536
[TBL] [Abstract][Full Text] [Related]
11. Recombinant activated factor VII in the management of massive obstetric bleeding.
Palomino MA; Chaparro MJ; de Elvira MJ; Curiel EB
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):226-7. PubMed ID: 16575264
[No Abstract] [Full Text] [Related]
12. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
Al-Ruzzeh S; Mahmoud A; Shah S; O'Regan D
Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
[No Abstract] [Full Text] [Related]
13. Successful management of bleeding with recombinant factor VIIa (NovoSeven) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins.
Culić S; Kuljis D; Armanda V; Jankovic S
Pediatr Blood Cancer; 2007 Sep; 49(3):332-5. PubMed ID: 16514611
[TBL] [Abstract][Full Text] [Related]
14. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
15. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
Hennewig U; Laws HJ; Eisert S; Göbel U
Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
[TBL] [Abstract][Full Text] [Related]
16. Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery.
Halkos ME; Levy JH; Chen E; Reddy VS; Lattouf OM; Guyton RA; Song HK
Ann Thorac Surg; 2005 Apr; 79(4):1303-6. PubMed ID: 15797067
[TBL] [Abstract][Full Text] [Related]
17. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
Gielen-Wijffels SE; van Mook WN; Ramsay G
Ned Tijdschr Geneeskd; 2003 Mar; 147(9):419. PubMed ID: 12661464
[No Abstract] [Full Text] [Related]
18. Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin.
Ng HJ; Koh LP; Lee LH
Ann Hematol; 2003 Apr; 82(4):257-8. PubMed ID: 12707733
[TBL] [Abstract][Full Text] [Related]
19. Successful use of recombinant factor VIIa in a patient with intractable bleeding during extracorporeal membrane oxygenation.
Brose S; Sirbu H; Engel M; Kuhlen R; Autschbach R
Thorac Cardiovasc Surg; 2005 Dec; 53(6):389-90. PubMed ID: 16311981
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
